Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Vitekta
(elvitegravir)
Uses, side effects, dosage information & price range
About this medicine
Vitekta co-administered with a ritonavir-boosted protease inhibitor and with other antiretroviral agents, is indicated for the treatment of human-immunodeficiency-virus-1 (HIV-1) infection in adults who are infected with HIV-1 without known mutations associated with resistance to elvitegravir.
Common Brand Names for this Composition
The following popular commercial brand names contain elvitegravir as their active ingredient composition:
Genvoya
Gilead Sciences Ireland UC
Stribild
Gilead Sciences Ireland UC
Vitekta
Gilead Sciences International Ltd
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
elvitegravir
Category
Antivirals for systemic use
Manufacturer
Gilead Sciences International Ltd
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.